The DOI matches its Crossref record; 285 of the 285 references it cites were found in a registry or an index.
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,154
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 11,772
(2007) · Cited by 6,530
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878 · cited 1×
“They are produced exclusively by a population of neurons in the lateral hypothalamic area (de Lecea et al., 1998; Sakurai et al., 1998).”
BackgroundEpidemiology of insomnia: what we know and what we still need to learn
Ohayon, M. M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0186 · Cited by 3,743 · cited 2×
“The prevalence rate of insomnia in the general population has been estimated as low as 5% to as high as 50% (Ohayon, 2002; Morin and Jarrin, 2013).”
BackgroundA review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Research works printed but not linked: 12
- Cates, 2009, Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients, Community Ment Health J, 45, 251, 10.1007/s10597-009-9200-0 · doi:10.1007/s10597-009-9200-0
- Dhillon, 2014, Tasimelteon: first global approval, Drugs, 74, 505, 10.1007/s40265-014-0200-1 · doi:10.1007/s40265-014-0200-1
- Enomoto, 2012, Effects of mirtazapine on sleep disturbance under neuropathic pain-like state, Synapse, 66, 483, 10.1002/syn.21532 · doi:10.1002/syn.21532
- Feeney, 2009, Melatonin agonist tasimelteon improves sleep in primary insomnia characterized by difficulty falling asleep, Sleep, 32, A43
- Laudon, 2012, Tolerability, pharmacokinetic and pharmacodynamic evaluation of multiple ascending doses of Neu-P11 in insomnia patients, Sleep, 35, A221
- Lovenberg, 1999, Cloning and functional expression of the human histamine H3 receptor, Mol Pharmacol, 55, 1101
- Neurim Pharmaceuticals (Tel-Aviv, Israel) (Press release Feb 18 2013) Neurim Pharmaceuticals announces positive Phase 2 clinical trial results of Piromelatine for the treatment of insomnia, Neurim Pharmaceuticals, Tel-Aviv, Israel
- Nilsen, 1992, Single dose pharmacokinetics of trazodone in healthy subjects, Pharmacol Toxicol, 71, 150, 10.1111/j.1600-0773.1992.tb00535.x · doi:10.1111/j.1600-0773.1992.tb00535.x
- Nilsen, 1993, Pharmacokinetics of trazodone during multiple dosing to psychiatric patients, Pharmacol Toxicol, 72, 286, 10.1111/j.1600-0773.1993.tb01651.x · doi:10.1111/j.1600-0773.1993.tb01651.x
- Robinson, 2013, Gabapentin shows promise in treating refractory insomnia in children, J Child Neurol, 28, 1618, 10.1177/0883073812463069 · doi:10.1177/0883073812463069
- Urade, 2003, Sleep regulation in adenosine A2A receptor-deficient mice, Neurology, 61, S94
- Vanda Pharmaceuticals Inc. (Press release, June 26, 2008) Phase III data show Vanda Pharmaceuticals’ tasimelteon (VEC-162) significantly improves sleep in patients with chronic insomnia, Vanda Pharmaceuticals, Rockville, MD
Cited by
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
Haack, M., Simpson, N., Sethna, N., Kaur, S., & Mullington, J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0439-z · Cited by 641
Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
Chitimus, D. M., Popescu, M. R., Voiculescu, S. E., Panaitescu, A. M., Pavel, B., Zagrean, L., & Zagrean, A.-M. (2020) · Biomolecules · doi:10.3390/biom10091211 · Cited by 354
Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz007 · Cited by 194
Off-Label Medication: From a Simple Concept to Complex Practical Aspects
Rusz, C.-M., Ősz, B.-E., Jîtcă, G., Miklos, A., Bătrînu, M.-G., & Imre, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910447 · Cited by 58
Involvement of the GABAA receptor α subunit in the mode of action of etifoxine
Mattei, C., Taly, A., Soualah, Z., Saulais, O., Henrion, D., Guérineau, N. C., Verleye, M., & Legros, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.034 · Cited by 26
Metadata
- Authors
- Atkin, T., Comai, S., & Gobbi, G.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 70
- Issue
- 2
- Pages
- 197-245
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2788590302
- Cited by
- 391
- References
- 285
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. https://app.cochat.ai/papers/10.1124/pr.117.014381
- The paper
- Atkin, T., Comai, S., & Gobbi, G. (2018). Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacological Reviews. https://doi.org/10.1124/pr.117.014381
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
